Atomicwork Announces FUSION'25, a Flagship CIO Leadership Conference in San Francisco
Join 100+ global CIOs on
Unlike traditional conferences, FUSION'25 is designed as a curated peer forum, because as AI evolves and organizations try to keep up, professionals learn best from their peers in the industry. Through keynote sessions, fireside conversations, and peer-to-peer dialogues, attendees will learn practical transformation playbooks and discuss the evolving role of IT in shaping business outcomes.
"CIOs are no longer operating behind the scenes, they're steering the enterprise," said
Speakers at FUSION'25 include business and technology leaders from Google, Microsoft, Ōura Ring and Zuora, who will share lessons on scaling business transformation, embedding trust into enterprise systems, and leading with clarity in an AI-driven era.
"Enterprise transformation today requires a lot more than technology. It requires business alignment and shared leadership," said
FUSION'25 underscores Atomicwork's mission to empower IT leaders not only with AI-powered service management, but also with the peer networks and leadership insights needed to thrive in the age of agentic AI and enterprise transformation.
To be part of this exclusive gathering of CIOs and IT leaders, request an invitation at fusion.atomicwork.com.
About Atomicwork
Atomicwork is a modern service management platform built for the AI era. With agentic AI, the platform automates routine IT tasks, unifies internal workflows, and delivers instant, contextual ITSM and ESM across Slack, Teams, and the browser - empowering IT teams to focus on strategic initiatives that drive business growth.
Trusted by seasoned CIOs and enterprise IT teams, Atomicwork transforms IT service management while delivering exceptional employee experiences. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/atomicwork-announces-fusion25-a-flagship-cio-leadership-conference-in-san-francisco-302543820.html
SOURCE Atomicwork Inc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
- Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026
- FDA Approves Genentech’s Tecentriq in Combination With a Fluoropyrimidine and Oxaliplatin for the Adjuvant Treatment of a Certain Type of Stage III Colon Cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share